PDCD1 and neoplasm: For example, preliminary evidence suggests that in the setting of anti-cytotoxic T-lymphocyte associated protein 4 (CTLA-4) or anti-PD-1 therapy, TLS gene expression may occur independently of the tumor’s mutational status [26].